Skip to main content

Christine H. Divers, PhD

Director, Health Economics and Outcomes Research, Bayer HealthCare Pharmaceuticals Inc
Dr Divers is Director, Health Economics and Outcomes Research, Bayer HealthCare Pharmaceuticals Inc
Authored Items
Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Atheer A. Kaddis, PharmD, Chakkarin Burudpakdee, PharmD, Anshul Shah, BS Pharm, MS, Vijay N Joish, PhD, Christine H. Divers, PhD, Avin Yaldo, PhD
December 2014 Vol 7, No 9 in Practice Management
Employer-Based Health Initiative: Impact on Employees? Cardiovascular Outcomes
Gene Reeder, RPh, PhD, Charles E. Collins, Jr., MS, MBA , Christine H. Divers, PhD, Del Deem, Becky J. Cherney, Gaye Fortner, RN, BSN, MSM, Louise Y. Probst
February/March 2009, Vol 2, No 2 in Practice Management
Last modified: December 23, 2014